vs
First Foundation Inc.（FFWM）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是First Foundation Inc.的1.2倍（$60.1M vs $48.4M），RHYTHM PHARMACEUTICALS, INC.净利率更高（-92.6% vs -97.9%，领先5.3%），First Foundation Inc.同比增速更快（421.7% vs 83.8%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs -2.7%）
约翰·B·拉克森海事基金会学院是位于菲律宾内格罗斯西部省巴科洛德市的私立海事学院，专注于培养海事领域专业人才，是当地具备影响力的海事专业高等教育机构。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
FFWM vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.2倍
$48.4M
营收增速更快
FFWM
高出337.9%
83.8%
净利率更高
RYTM
高出5.3%
-97.9%
两年增速更快
RYTM
近两年复合增速
-2.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $48.4M | $60.1M |
| 净利润 | $-8.0M | $-55.6M |
| 毛利率 | — | 88.1% |
| 营业利润率 | -97.5% | -87.1% |
| 净利率 | -97.9% | -92.6% |
| 营收同比 | 421.7% | 83.8% |
| 净利润同比 | 43.0% | — |
| 每股收益（稀释后） | $-0.09 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FFWMRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $48.4M | $57.3M | ||
| Q3 25 | $63.6M | $51.3M | ||
| Q2 25 | $51.4M | $48.5M | ||
| Q1 25 | $71.4M | $32.7M | ||
| Q4 24 | $9.3M | $41.8M | ||
| Q3 24 | $9.2M | $33.3M | ||
| Q2 24 | $57.5M | $29.1M |
净利润FFWMRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $-8.0M | $-47.5M | ||
| Q3 25 | $-146.3M | $-52.9M | ||
| Q2 25 | $-7.7M | $-46.6M | ||
| Q1 25 | $6.9M | $-49.5M | ||
| Q4 24 | $-14.1M | $-43.3M | ||
| Q3 24 | $-82.2M | $-43.6M | ||
| Q2 24 | $3.1M | $-32.3M |
毛利率FFWMRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% |
营业利润率FFWMRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | -97.5% | -82.2% | ||
| Q3 25 | -92.7% | -102.6% | ||
| Q2 25 | -21.1% | -93.4% | ||
| Q1 25 | 8.8% | -143.7% | ||
| Q4 24 | -247.7% | -98.6% | ||
| Q3 24 | -1276.7% | -132.0% | ||
| Q2 24 | 4.6% | -139.2% |
净利率FFWMRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | -97.9% | -83.0% | ||
| Q3 25 | -230.1% | -103.1% | ||
| Q2 25 | -15.0% | -96.1% | ||
| Q1 25 | 9.7% | -151.4% | ||
| Q4 24 | -152.2% | -103.6% | ||
| Q3 24 | -896.9% | -131.2% | ||
| Q2 24 | 5.4% | -110.9% |
每股收益（稀释后）FFWMRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-0.09 | $-0.73 | ||
| Q3 25 | $-1.78 | $-0.82 | ||
| Q2 25 | $-0.09 | $-0.75 | ||
| Q1 25 | $0.08 | $-0.81 | ||
| Q4 24 | $-0.24 | $-0.71 | ||
| Q3 24 | $-1.23 | $-0.73 | ||
| Q2 24 | $0.05 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $912.6M | $122.9M |
| 总资产 | $11.9B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FFWMRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $1.6B | $388.9M | ||
| Q3 25 | $1.7B | $416.1M | ||
| Q2 25 | $1.1B | $291.0M | ||
| Q1 25 | $1.0B | $314.5M | ||
| Q4 24 | $1.0B | $320.6M | ||
| Q3 24 | $1.1B | $298.4M | ||
| Q2 24 | $1.4B | $319.1M |
股东权益FFWMRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $912.6M | $139.1M | ||
| Q3 25 | $917.9M | $148.8M | ||
| Q2 25 | $1.1B | $-11.9M | ||
| Q1 25 | $1.1B | $18.9M | ||
| Q4 24 | $1.1B | $21.7M | ||
| Q3 24 | $1.1B | $11.2M | ||
| Q2 24 | $933.2M | $39.3M |
总资产FFWMRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $11.9B | $480.2M | ||
| Q3 25 | $11.9B | $506.9M | ||
| Q2 25 | $11.6B | $372.7M | ||
| Q1 25 | $12.6B | $386.7M | ||
| Q4 24 | $12.6B | $392.3M | ||
| Q3 24 | $13.4B | $363.6M | ||
| Q2 24 | $13.7B | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-31.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-35.2M | — |
| 自由现金流率自由现金流/营收 | -72.8% | — |
| 资本支出强度资本支出/营收 | 6.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-45.9M | — |
8季度趋势，按日历期对齐
经营现金流FFWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | $-31.9M | $-25.4M | ||
| Q3 25 | $9.2M | $-26.6M | ||
| Q2 25 | $-16.3M | $-23.3M | ||
| Q1 25 | $-552.0K | $-40.4M | ||
| Q4 24 | $-8.7M | $-18.8M | ||
| Q3 24 | $14.2M | $-25.2M | ||
| Q2 24 | $-9.1M | $-29.1M |
自由现金流FFWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | $-35.2M | — | ||
| Q3 25 | $8.6M | — | ||
| Q2 25 | $-16.7M | — | ||
| Q1 25 | $-2.5M | — | ||
| Q4 24 | $-11.4M | — | ||
| Q3 24 | $13.4M | — | ||
| Q2 24 | $-9.4M | — |
自由现金流率FFWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | -72.8% | — | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | -32.4% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | -123.5% | — | ||
| Q3 24 | 146.2% | — | ||
| Q2 24 | -16.3% | — |
资本支出强度FFWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | 6.9% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 29.4% | — | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 0.4% | — |
现金转化率FFWMRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.96× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
